1. Home
  2. DSS vs TCRT Comparison

DSS vs TCRT Comparison

Compare DSS & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DSS Inc.

DSS

DSS Inc.

HOLD

Current Price

$0.56

Market Cap

5.5M

ML Signal

HOLD

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$1.76

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSS
TCRT
Founded
1984
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
4.9M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
DSS
TCRT
Price
$0.56
$1.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.0K
8.9K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
42.45
24.66
EPS
N/A
N/A
Revenue
$2,085,000.00
$15,900,000.00
Revenue This Year
$1.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$1.75
52 Week High
$1.90
$4.57

Technical Indicators

Market Signals
Indicator
DSS
TCRT
Relative Strength Index (RSI) 51.85 29.15
Support Level $0.55 N/A
Resistance Level $0.58 $2.02
Average True Range (ATR) 0.04 0.09
MACD 0.01 -0.01
Stochastic Oscillator 71.51 9.37

Price Performance

Historical Comparison
DSS
TCRT

About DSS DSS Inc.

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Share on Social Networks: